The expression of opticin in vitreous body and retina of diabetes mellitus rats

1. Reardon AJ, Le Goff M, Briggs MD, McLeod D, Sheehan JK, Thornton DJ, et al. Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix. J Biol Chem. 2000; 275:2123-9.10.1074/jbc.275.3.2123Search in Google Scholar

2. Ramesh S, Bonshek RE, Bishop PN. Immunolocalisation of opticin in the human eye. Br J Ophthalmol. 2004; 88:697-702.10.1136/bjo.2003.031989Open DOISearch in Google Scholar

3. Hindson VJ, Gallagher JT, Halfter W, Bishop PN. Opticin binds to heparan and chondroitin sulfate proteoglycans. Invest Ophthalmol Vis sci. 2005; 46: 4417-23.10.1167/iovs.05-0883Search in Google Scholar

4. Forrester JV. Shedding light on a new eye protein. Br J Ophthalmol. 2004; 88:602-3.10.1136/bjo.2003.034918Open DOISearch in Google Scholar

5. Le Goff MM, Slevin MA, Bishop PN. Opticin is an inhibitor of VEGF-A and FGF-2-activated angiogenesis. Invest Ophthalmol Vis Sci. 2005; 46:S451.Search in Google Scholar

6. Le Goff MM, Hindson VJ, Jowitt TA, Scott PG, Bishop PN. Characterization of opticin and evidence of stable dimerization in solution. J Biol Chem. 2003; 278: 45280-7.10.1074/jbc.M303117200Search in Google Scholar

7. Friedman JS, Faucher M, Hiscott P, Biron VL, Malenfant M, Turcotte P, et al. Protein localization in the human eye and genetic screen of opticin. Hum Mol Genet. 2002; 11:1333-42.10.1093/hmg/11.11.1333Open DOISearch in Google Scholar

8. Le Goff MM, Slevin MA, Bishop PN. Opticin is an inhibitor of VEGF-A and FGF-2-activated angiogenesis. Annual Invest Ophthalmol Vis Sci. 2005; 46:451.Search in Google Scholar

9. Sanders EJ, Walter MA, Parker E, Arámburo C, Harvey S. Opticin binds retinal growth hormone in the embryonoic vitreous. Invest Ophthalmol Vis Sci. 2003; 44:5404-9.10.1167/iovs.03-0500Search in Google Scholar

10. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27: 283-90.10.1016/S0278-5846(03)00023-XOpen DOISearch in Google Scholar

11. Hobby P, Wyatt MK, Gan W, Bernstein S, Tomarev S, Slingsby C, et al. Cloning , modeling , and chromosomal localization for a small leucine-rich repeat proteoglycan (SLRP) family member expressed in human eye. Mol Vis. 2000; 6:72-8.Search in Google Scholar

12. Sulochana KN, Fan H, Jois S, Subramanian V, Sun F, Kini RM, et al. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis. J Biol Chem. 2005; 280:27935-48.10.1074/jbc.M41432020015923192Search in Google Scholar

13. Matthew JS, Magali LG, David W, Paul B, Mark S. Antiangiogenic properties of opticin. The FASEB Journal. 2007; 21:601.Search in Google Scholar

14. Nyberg P, Xie L, Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res. 2005; 65:3967-79.10.1158/0008-5472.CAN-04-242715899784Open DOISearch in Google Scholar

15. Sneddon SF, Telfer BA, Williams KJ, Bishop PN, Stratford IJ, Cowen RL. Opticin:a potent antiangiogenic/antiproliferative agent for breast cancer therapy. Breast Cancer Research. 2010; 12:53-63.10.1186/bcr2550Open DOISearch in Google Scholar

16. Pattwell DM, Sheridan CM, Le Goff M, Bishop PN, Hiscott P. Localisation of opticin in human proliferative retinal disease. Exp Eye Res. 2010; 90:461-4. 10.1016/j.exer.2009.12.00720036236Open DOISearch in Google Scholar